Am J Psychiatry 159:122-129, January 2002
© 2002 American Psychiatric Association
Changes in Brain Function of Depressed Subjects During Treatment With Placebo
Andrew F. Leuchter, M.D.,
Ian A. Cook, M.D.,
Elise A. Witte, Ph.D.,
Melinda Morgan, Ph.D., and
Michelle Abrams, R.N.
OBJECTIVE: It has been proposed that 50%–75% of the efficacy of antidepressant medication represents the placebo effect, since many depressed patients improve when treated with either medication or placebo. This study examined brain function in depressed subjects receiving either active medication or placebo and sought to determine whether quantitative electroencephalography (QEEG) could detect differences in brain function between medication and placebo responders. Both QEEG power and cordance, a new measure that reflects cerebral perfusion and is sensitive to the effect of antidepressant medication, were examined. METHOD: Fifty-one subjects with major depression were enrolled in one of two independent, 9-week double-blind, placebo-controlled studies in which either fluoxetine (N=24) or venlafaxine (N=27) was the active medication. Serial QEEG recordings were performed during the course of treatment. After 9 weeks, the blind was broken and subjects were classified as medication responders, placebo responders, medication nonresponders, or placebo nonresponders. RESULTS: No significant pretreatment differences in clinical or QEEG measures were found among the four outcome groups. Placebo responders, however, showed a significant increase in prefrontal cordance starting early in treatment that was not seen in medication responders (who showed decreased cordance) or in medication nonresponders or placebo nonresponders (who showed no significant change). There was no significant change in QEEG power during treatment. CONCLUSIONS: These findings suggest that "effective" placebo treatment induces changes in brain function that are distinct from those associated with antidepressant medication. If these results are confirmed, cordance may be useful for differentiating between medication and placebo responders.
This article has been cited by other articles:
|
|
|
|
 
S. M. Berman, B. D. Naliboff, B. Suyenobu, J. S. Labus, J. Stains, G. Ohning, L. Kilpatrick, J. A. Bueller, K. Ruby, J. Jarcho, et al.
Reduced Brainstem Inhibition during Anticipated Pelvic Visceral Pain Correlates with Enhanced Brain Response to the Visceral Stimulus in Women with Irritable Bowel Syndrome
J. Neurosci.,
January 9, 2008;
28(2):
349 - 359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. GIBBONS
Dr. Gibbons Replies
Am J Psychiatry,
December 1, 2007;
164(12):
1908 - 1910.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Olshansky
Placebo and Nocebo in Cardiovascular Health: Implications for Healthcare, Research, and the Doctor-Patient Relationship
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
415 - 421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hunter, A. F. Leuchter, M. L. Morgan, and I. A. Cook
Changes in Brain Function (Quantitative EEG Cordance) During Placebo Lead-In and Treatment Outcomes in Clinical Trials for Major Depression
Am J Psychiatry,
August 1, 2006;
163(8):
1426 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Vallance
Something out of nothing: the placebo effect
Advan. Psychiatr. Treat.,
July 1, 2006;
12(4):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rajagopal
The placebo effect
Psychiatr. Bull.,
May 1, 2006;
30(5):
185 - 188.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Venneman, A. Leuchter, G. Bartzokis, M. Beckson, S. L. Simon, M. Schaefer, R. Rawson, T. Newton, I. A. Cook, S. Uijtdehaage, et al.
Variation in Neurophysiological Function and Evidence of Quantitative Electroencephalogram Discordance: Predicting Cocaine-Dependent Treatment Attrition
J Neuropsychiatry Clin Neurosci,
May 1, 2006;
18(2):
208 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Galanter
Innovations: Alcohol & Drug Abuse: Spirituality in Alcoholics Anonymous: A Valuable Adjunct to Psychiatric Services
Psychiatr Serv,
March 1, 2006;
57(3):
307 - 309.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Di Blasi and J. Kleijnen
Context Effects: Powerful Therapies or Methodological Bias?
Eval Health Prof,
June 1, 2003;
26(2):
166 - 179.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Benedetti, A. Pollo, L. Lopiano, M. Lanotte, S. Vighetti, and I. Rainero
Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses
J. Neurosci.,
May 15, 2003;
23(10):
4315 - 4323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. HO
Change in Brain Function With Placebo
Am J Psychiatry,
February 1, 2003;
160(2):
387 - 388.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. MULLER
Brain Changes and Placebo
Am J Psychiatry,
February 1, 2003;
160(2):
389 - 390.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Di Blasi, T. J Kaptchuk, J. Weinman, and J. Kleijnen
Informing participants of allocation to placebo at trial closure: postal survey
BMJ,
December 7, 2002;
325(7376):
1329 - 1329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Benedetti
How the Doctor's Words Affect the Patient's Brain
Eval Health Prof,
December 1, 2002;
25(4):
369 - 386.
[Abstract]
[PDF]
|
|
|
|
|
|
|
How Placebo Affects the Depressed Brain
Journal Watch Psychiatry,
February 6, 2002;
2002(206):
1 - 1.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
